Waystar (NASDAQ:WAY) Research Coverage Started at Barclays

Barclays initiated coverage on shares of Waystar (NASDAQ:WAY) in a report issued on Tuesday, MarketBeat.com reports. The firm issued an overweight rating and a $24.00 target price on the stock.

Other analysts have also recently issued research reports about the stock. Raymond James initiated coverage on shares of Waystar in a research note on Tuesday. They set an outperform rating and a $30.00 price target for the company. JPMorgan Chase & Co. initiated coverage on shares of Waystar in a research note on Tuesday. They set an overweight rating and a $24.00 price target for the company. Royal Bank of Canada initiated coverage on shares of Waystar in a research note on Tuesday. They set an outperform rating and a $27.00 price target for the company. Evercore ISI initiated coverage on shares of Waystar in a research report on Tuesday. They set an outperform rating and a $25.00 price objective for the company. Finally, Deutsche Bank Aktiengesellschaft initiated coverage on shares of Waystar in a research report on Tuesday. They set a buy rating and a $27.00 price objective for the company. Eleven analysts have rated the stock with a buy rating, According to data from MarketBeat.com, Waystar presently has an average rating of Buy and a consensus price target of $27.60.

Waystar Stock Down 0.0 %

Shares of NASDAQ:WAY opened at $21.50 on Tuesday. Waystar has a 1-year low of $20.50 and a 1-year high of $23.09.

Waystar Company Profile

Waystar Holding Corp. is a software company which provide healthcare payments. Waystar Holding Corp. is based in LEHI, Utah.